HCIT & Life Sciences

"We have greatly appreciated AGC Partners' continuous commitment to Greenphire over the past several years and their work during our process. Hugh Hoffman's expertise and knowledge, not only in Clinical Trials but across the broader ecosystem of Life Sciences Technology and HCIT, was highly valuable in the positioning of Greenphire for our successful outcome. Coupled with the great support of Ben Howe and the 24x7 execution of the broader AGC Team, AGC Partners is highly regarded by The Riverside Company and Greenphire."

Led by Fred, Team AGC did an amazing job from project launch to close date. Navigating through this maze of rather complex steps, especially during COVID, was somewhat intimidating but AGC guided and supported us through the whole process. I just can't see how we would have been able to plow through this critical work without the sound advice of M&A advisors of that caliber. Fred was able to translate what made STACS DNA a leader in its field into a compelling and concrete story for potential investors and conducted this exercise where we ultimately moved forward with a best-in-class partner. AGC came highly recommended, and I now see why. I would recommend them without reservation. It was a pleasure working with Fred, Daniel, Zack and Patrick and praise all the great work they did for us.